BioCentury | Nov 3, 2008
Company News

CellTran, York Pharma deal

...York acquired the marketed products, clinical pipeline and manufacturing facilities of fellow dermatology company CellTran for...
...a hydrogel wound dressing for which the company will seek CE Mark approval in Europe. CellTran...
...sulfadiazine and Flammacerium silver sulfadiazine/cerium nitrate Solvay S.A. (Euronext:SOLB, Brussels, Belgium) (see BioCentury, Oct. 13). CellTran Ltd....
BioCentury | Sep 29, 2008
Product Development

Ophthalmic deals

...selected by Fovea and Genzyme's gene delivery technologies Nov 07 CellTran/Ilika Undisclosed Partner to develop CellTran's...
BioCentury | Nov 19, 2007
Company News

CellTran, Ilika Technologies Ltd. deal

...CellTran and Ilika partnered to develop CellTran's corneal stem cell therapy delivered using plasma polymerization technology...
...corneal damage next year. Ilika will be responsible for commercialization. Further terms were not disclosed. CellTran Ltd....
BioCentury | Oct 9, 2006
Company News

CellTran, Innogenetics deal

...now owns about 42% of CellTran and has an option to increase that to 51%. CellTran...
...sheets derived from donor keratinocytes. CellTran expects both products to be marketed within 6 months. CellTran...
...Morich and Christian Matton, INNX's VP of legal and intellectual property, will join CellTran's board. CellTran Ltd....
Items per page:
1 - 4 of 4
BioCentury | Nov 3, 2008
Company News

CellTran, York Pharma deal

...York acquired the marketed products, clinical pipeline and manufacturing facilities of fellow dermatology company CellTran for...
...a hydrogel wound dressing for which the company will seek CE Mark approval in Europe. CellTran...
...sulfadiazine and Flammacerium silver sulfadiazine/cerium nitrate Solvay S.A. (Euronext:SOLB, Brussels, Belgium) (see BioCentury, Oct. 13). CellTran Ltd....
BioCentury | Sep 29, 2008
Product Development

Ophthalmic deals

...selected by Fovea and Genzyme's gene delivery technologies Nov 07 CellTran/Ilika Undisclosed Partner to develop CellTran's...
BioCentury | Nov 19, 2007
Company News

CellTran, Ilika Technologies Ltd. deal

...CellTran and Ilika partnered to develop CellTran's corneal stem cell therapy delivered using plasma polymerization technology...
...corneal damage next year. Ilika will be responsible for commercialization. Further terms were not disclosed. CellTran Ltd....
BioCentury | Oct 9, 2006
Company News

CellTran, Innogenetics deal

...now owns about 42% of CellTran and has an option to increase that to 51%. CellTran...
...sheets derived from donor keratinocytes. CellTran expects both products to be marketed within 6 months. CellTran...
...Morich and Christian Matton, INNX's VP of legal and intellectual property, will join CellTran's board. CellTran Ltd....
Items per page:
1 - 4 of 4